Skip to main content
. 2023 Jun 28;55(2):60–69. doi: 10.1051/ject/2023017

Table 7.

Prothrombin complex concentrates (PCC) administration.

Control group ROTEM group P
rFVIIa (N) (ug/kg) (12) 143 ± 46 (10) 65 ± 30 0.0001
FEIBA (N) (ut/kg) (7) 37 ± 33 0 0.02
KcentraTM (N) (ut/kg) (3) 37 ± 21 (37) 22 ± 12 <0.00001

rFVIIa: activated recombinant factor VII; FEIBA: factor eight inhibitor bypass activity; KcentraTM: prothrombin complex concentrate (human).